Nocturne Acquisition Corporation

Nocturne Acquisition Corporation

MBTCU
Nocturne Acquisition CorporationUS flagNASDAQ Capital Market
10.41
USD
-0.58
- -
60.53MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Henry Monzon
Full Time Employees
2
Sector
Financial Services
Industry
Shell Companies
Address
3 Germay Drive Wilmington DE United States of America 19804
IPO Date
Mar 31, 2021
Business
Nocturne Acquisition Corporation (NASDAQ:MBTCU) is a blank check company with no significant operations that intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, initially focusing on targets offering disruptive technologies in the blockchain/crypto and artificial intelligence sectors with equity values between $300 million and $1 billion. Incorporated in 2020 as a Cayman Islands exempted company and headquartered in Wilmington, Delaware, the company provides no core products or services beyond its SPAC structure, including units comprising one ordinary share and one right to receive one-tenth of an ordinary share upon a successful business combination. It raised $115 million in its March 2021 initial public offering, with proceeds placed in trust; in April 2024, following the termination of its proposed merger with Cognos Therapeutics, Inc.—a developer of implantable drug delivery devices for neurological diseases including brain cancer—the company liquidated its trust account, redeemed all public shares at approximately $11.79 per share, cancelled outstanding shares, delisted from Nasdaq via Form 25, and filed Form 15 to terminate SEC registration, concluding its operations as a SPAC without completing a business combination.

Company News

APIChat
  • Nocturne Acquisition Corporation Announces Termination and Liquidation of Trust Account

  • Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting Date

  • Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting Date

  • Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting

  • Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting

  • Nocturne Acquisition Corporation Announces Filing of a Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Cognos

  • Nocturne Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

  • Nocturne Acquisition Corporation Announces the Separate Trading of its Ordinary Shares and Rights, Commencing May 3, 2021

  • Nocturne Acquisition Corporation Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering